logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (iv) All outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates21.846.664.568.065.864.461.354.714166432422
Cocaine7.116.820.621.323.122.623.018.44807812199
Stimulants3.65.13.42.72.32.72.43.3112793834
Hypnotics and sedatives1.81.11.42.23.55.17.713.750951897
Hallucinogens0.10.30.30.30.20.20.30.3799474
Volatile substances0.50.60.10.00.10.10.10.11009344
Cannabis 63.228.59.14.73.93.53.26.26704231200
Other substances 1.90.90.60.81.01.42.03.428681360
Total3819712290060435275021446175713756301227783483730
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012